ERVIN GRAVES STRATEGY GROUP, LLC

Lobbying for AMERICAN MEDICINES COMPANY · Manufacturer of Generic Medication

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $30,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Health Issues

Appropriations/Funding and Support for strengthening the domestic supply chain for generic medication manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.